AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Daclatasvir Dihydrochloride in Zambia
1 product registered with ZAMRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Mydekla 60 Tablets Film-coated Tablets | 014/066 | Mylan Laboratories Limited | active | 11 Jul 2030 |
Daclatasvir Dihydrochloride — ZAMRA Registration Details
ZAMRA (Zambia) has 1 registered product containing Daclatasvir Dihydrochloride, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Daclatasvir Dihydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.